Page last updated: 2024-11-04

sulfinpyrazone and Pulmonary Hypertension

sulfinpyrazone has been researched along with Pulmonary Hypertension in 4 studies

Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.

Research Excerpts

ExcerptRelevanceReference
"Altering the platelet behavior with sulfinpyrazone or heparin--probably by inhibiting the platelet release reaction--reduces the emboli-induced pulmonary hypertension to the same extent as platelet depletion."3.65Platelet-mediated pulmonary hypertension: reduction by platelet inhibition. ( Grover, RF; Mlczoch, J; Reeves, JT, 1977)
"Our results suggest that hypoxemia is associated with shortened platelet survival time and that platelets may, therefore, be involved in the thromboembolic complications that develop in patients with hypoxemia."1.26Platelet survival time in patients with hypoxemia and pulmonary hypertension. ( Ellis, JH; Genton, E; Steele, P; Weily, HS, 1977)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19904 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mlczoch, J2
Tucker, A1
Weir, EK1
Reeves, JT2
Grover, RF2
Steele, P1
Ellis, JH1
Weily, HS1
Genton, E1
Keith, IM1
Will, JA1
Huxtable, RJ1
Weir, K1

Other Studies

4 other studies available for sulfinpyrazone and Pulmonary Hypertension

ArticleYear
Platelet-mediated pulmonary hypertension and hypoxia during pulmonary microembolism: reduction by platelet inhibition.
    Chest, 1978, Volume: 74, Issue:6

    Topics: Animals; Blood Platelets; Dogs; Female; Heparin; Hypertension, Pulmonary; Hypoxia; Male; Pulmonary E

1978
Platelet survival time in patients with hypoxemia and pulmonary hypertension.
    Circulation, 1977, Volume: 55, Issue:4

    Topics: Blood Platelets; Cell Survival; Female; Humans; Hypertension, Pulmonary; Hypoxia; Male; Oxygen; Sulf

1977
Platelet-mediated pulmonary hypertension: reduction by platelet inhibition.
    Progress in biochemical pharmacology, 1977, Volume: 13

    Topics: Animals; Blood Platelets; Dogs; Heparin; Hypertension, Pulmonary; Pulmonary Circulation; Pulmonary E

1977
Anti-platelet agents reduce morphological changes of chronic hypoxic pulmonary hypertension.
    Histology and histopathology, 1987, Volume: 2, Issue:2

    Topics: Animals; Dipyridamole; Flunarizine; Heart; Heart Ventricles; Hypertension, Pulmonary; Hypoxia; Male;

1987